Skip to main content
. 2022 May 4;63(5):5. doi: 10.1167/iovs.63.5.5

Table 2.

Full-Field Electroretinogram Findings of Patients Diagnosed with Mitochondrial Disease

Dark-Adapted 0.01 ERG (OD/OS) Dark-Adapted 3.0 ERG (OD/OS) Light-Adapted ERG (OD/OS)
Patient Amplitude a-Wave b-Wave a-Wave b-Wave 30-Hz 30-Hz Flicker
Diagnosis ID (µV) IT (ms) (µV) (µV) (µV) (µV) Flicker (µV) IT (ms)
LHON P1 185.6/173.4 78/76 –167.3/–149.1 282.4/72.8 –32.3/–28.7 72.7/69.9 72.0/70.7 31.5/31
P2 215.7/241.8 83/82 –175.6/–208.5 290.3/354.7 –31.2/–34.9 87.7/94.2 73.23/68.26 26/26
P3 245.3/216.8 80/84 –199.9/–147.8 358.7/266.1 –39.3/–33.6 114.2/88.49 97.9/84.6 29/29
P4 90.4/216.5 83.5/90 –58.4/–120.9 120.0/337.1 NA*/–20.9 NA*/64.3 21.9/43.4 30.5/31.5
P5 130.1/131.1 84.5/82 –110.4/–131.5 207.8/218.6 –5.9/–38.4 43.2/50.2 56.5/56.5 29/29
P6 267.9/284.1 84/90 –194.6/–207.9 369.7/373.3 –13.2/–20.6 86.8/105.6 65.1/72.8 31/29.5
P7 343.5/218.4 91.5/106 –174.2/–108.1 430.6/401.8 –18.5/–19.4 79.2/61.4 65.4/49.1 31.5/32
OPA1 P8 272.7/256.6 83/84.5 –114.7/–90.8 456.3/419.1 –30.2/–53.9 95.95/103.8 61.8/77.4 30.5/30.5
P9 192.8/148.6 85/104 –149.8/–136.5 276.2/225.8 –37.4/–22.6 94.1/72.3 84.0/78.1 28/28
P10 (son of P9) 204.7/160.3 80/93 –153.5/–135.2 363.9/351.6 –25.5/–36.9 99.9/95.5 90.3/75.5 28/29
P11 363.8/367.1 85/81.5 –149.8/–89.1 456.4/469.8 –29.5/–26.7 121.2/161.8 58.3/92.0 28/26.5
P12 312.1/255.8 76/76 –228.9/–195.4 415.1/312.5 –41.7/–16.7 110/84.4 87.5/67.8 28.5/27.5
P13 (son of P12) 325.2/198.8 100/78 –201.3/–187.8 381.0/332.5 –21.2/–33.7 55.1/82.8 35.3/36.7 29/28
OPA13 P14 (16 y) 146.4/128.5 98.5/96.5 –118.7/–104.7 185.6/161.2 –20.3/–16.2 60.1/67.2 59.6/73 29/28.5
P14 (23 y) 56.7/54.4 80/85 –65.3/–52.8 94.0/70.0 –23.9/–21.5 47.6/43.9 50.4/36.1 29/29
Normal reference 218.5 ± 148.3 85.9 ± 14.1 −210.1 ± 172.1 347.0 ± 134.1 −36.4 ± 25.8 109.8 ± 67.8 121.4 ± 65.5 26.3 ± 3.8

IT, implicit time; NA, not available.

*Very low amplitude that was undetectable.